Out of 16 BRAF-positive prostatic carcinomas, 2 were tubulopapillary adenocarcinomas, 6 were mixed solid-tubular adenocarcinomas, and 8 were prostatic urethral carcinomas. This evidence concerns the gene BRAF and prostate carcinoma.